Transcranial magnetic stimulation (TMS) is an effective treatment for depression but is
limited in that the optimal therapeutic target remains unknown. Early TMS trials lacked a …

Patients with major depressive disorder (MDD) may be refractory to or have
contraindications that preclude treatment with antidepressant pharmacotherapies …

Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex
(DLPFC) is an established treatment for refractory depression, however, therapeutic …

Disruption in reciprocal connectivity between the right anterior insula and the left
dorsolateral prefrontal cortex is associated with depression and may be a target for …

Repetitive transcranial magnetic stimulation (rTMS) is an effective and evidence-based
therapy for treatment-resistant major depressive disorder. A conventional course of rTMS …

Major depressive disorder (MDD) is a devastating mental disorder that affects up to 17% of
the population worldwide. Although brain-wide network-level abnormalities in MDD patients …

Background Repetitive transcranial magnetic stimulation (rTMS) is the current treatment
option for major depression (MD). Theta-burst stimulation (TBS), a variation of rTMS, affords …

Background The efficacy of repetitive transcranial magnetic stimulation (rTMS) for
depression may vary depending on the subregion stimulated within the dorsolateral …

There is growing interest in accelerated rTMS dosing regimens, wherein multiple sessions of
rTMS are applied per day. This Phase IV study evaluated the safety, efficacy, and durability …

The number of patients suffering from long-COVID is currently increasing rapidly, even after
the acute symptoms of COVID-19 have improved. The objective of this study was to …